Press Releases
// Mar 18, 2021
ElevateBio Announces Chief Scientific Officer of Regenerative Medicine, Melissa Carpenter, PhD, Elected to the International Society for Stem Cell Research Board of Directors
// Mar 15, 2021
ElevateBio Scales Disruptive Cell and Gene Therapy Business Model with $525 Million Series C Financing
// Jan 19, 2021
ElevateBio Announces Andrew Sandford Joins as President of ElevateBio BaseCamp
// Jan 08, 2021
ElevateBio to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
// Jan 08, 2021
ElevateBio to Present at the 39th Annual J.P. Morgan Healthcare Conference
// Dec 06, 2020
ElevateBio’s HighPassBio Presents on Novel T Cell Receptor Cell Therapy for Leukemia Relapse at 62nd Annual ASH Meeting
// Nov 16, 2020
ElevateBio and AgBiome Announce LifeEDIT Will Join ElevateBio’s Portfolio of Innovative Cell and Gene Therapy Companies
// Aug 25, 2020
